Insider Transactions in Q4 2025 at Nova Bay Pharmaceuticals, Inc. (NBY)

NBY Quotes by TradingView

Insider Transaction List (Q4 2025)

Date Insider Transaction Ownership Type Shares Traded Value / Price
Oct 21 2025
Michael John Kazley Chief Executive Officer
BUY
Conversion of derivative security
Indirect
56,806,080 +50.0%
-
Oct 21 2025
R01 Fund LP > 10% Shareholder
BUY
Conversion of derivative security
Direct
56,806,080 +50.0%
-
Oct 21 2025
Framework Ventures Iv L.P. > 10% Shareholder
BUY
Conversion of derivative security
Direct
56,806,080 +50.0%
-

Track Institutional and Insider Activities on NBY

Follow NovaBay Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBY shares.

Notify only if

Insider Trading

Get notified when an Nova Bay Pharmaceuticals, Inc. insider buys or sells NBY shares.

Notify only if

News

Receive news related to NovaBay Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NBY